REPLIMUNE LIMITED

Active
Company number 09496393Private limited companyIncorporated 2015

Key figures

−18,311,674 USD+47.6%
Net assets 2025/26
-80 m-60 m-40 m-20 m02021/222022/232023/242024/252025/26

Amounts are in USD (the currency of the accounts).

REPLIMUNE LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025/26

Sector comparison

SIC 72110

Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).

Company age11.7 years
Older than 78% · median 5.4 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.

Summary: REPLIMUNE LIMITED

What kind of company is it?

REPLIMUNE LIMITED is a private limited company registered with Companies House under company number 09496393. It was incorporated on 18 Mar 2015. Its status is active. The registered office is in Abingdon (OX14). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

How is the company doing financially?

The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files full accounts. Loss for the year was 247,674,374 USD. Net assets were −18,311,674 USD, up 47.6% on the previous year. Cash at bank and in hand was 4,439,720 USD. Total assets were 10,874,053 USD and total liabilities 28,163,219 USD. The company had an average of 79 employees. Figures are available for 5 financial years (2021/22–2025/26).

How does it compare with similar companies?

Compared with 3,991 active companies whose first SIC code is 72110: It is older than 78% of them (median age 5.4 years).

What do public registers and reports show?

It appears on the Home Office register of licensed sponsors (Global Business Mobility: Senior or Specialist Worker, Skilled Worker). HMRC lists it as an importer of goods, mainly miscellaneous chemicals, optical, medical and measuring instruments, pharmaceuticals. HMRC lists it as an exporter of goods, mainly optical, medical and measuring instruments.

Who runs and controls the company?

The company has 3 current directors. One person with significant control is registered. 4 of 6 registered charges are outstanding.

When are its next filings due?

The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 1 Apr 2027.

Filed accounts2021/22–2025/26
2021/222022/232023/242024/252025/26
Profit for the year-66,045,854-148,790,161-201,644,487-214,693,315-247,674,374
Cash at bank and in hand4,627,3201,158,0851,752,7032,393,4244,439,720
Total assets7,648,4019,157,35910,677,4749,958,41110,874,053
Total liabilities17,640,20733,485,17284,036,12943,624,65528,163,219
Net assets / total equity-8,769,115-26,352,439-75,210,152-34,943,259-18,311,674
Average number of employees5153656879
Average pay (per year)128,72099,457121,14796,038111,426

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The Company was incorporated on 18 March 2015 as an investor-funded research and development company, based in the UK and with a US corporate parent and support office. The Company specialises in developing an emerging class of cancer therapeutics, known as oncolytic immunotherapy.

As described in the company's latest filed accounts.

Registers and licences

Sponsor licence‡
Licence type and rating
Worker (A rating)
Routes
Global Business Mobility: Senior or Specialist Worker, Skilled Worker

On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.

International trade‡

Listed by HMRC as an importer of goods in 9 of the last 12 months on record, most recently July 2026. Main goods: miscellaneous chemicals, optical, medical and measuring instruments and pharmaceuticals.

Listed by HMRC as an exporter of goods in 1 of the last 12 months on record, most recently November 2025. Main goods: optical, medical and measuring instruments.

From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.

Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.

History

28 events
  1. Financial year 2025/26 endedAccounts: net assets −18.3m USD, 79 employees
  2. Financial year 2024/25 endedAccounts: net assets −34.9m USD, 68 employees
  3. Colin LOVE resignedDirector
  4. Philip ASTLEY-SPARKE resignedDirector
  5. Shawn GLIDDEN appointedDirector
  6. Emily HILL appointedDirector
  7. Sushil PATEL appointedDirector
  8. Financial year 2023/24 endedAccounts: net assets −75.2m USD, 65 employees
Earlier events (20)
  1. Financial year 2022/23 endedAccounts: net assets −26.4m USD, 53 employees
  2. Financial year 2021/22 endedAccounts: net assets −£8.8m, 51 employees
  3. Replimune Group, Inc. registered as a person with significant control
  4. Jason Paul RHODES resignedDirector
  5. Hugo Alexander SLOOTWEG resignedDirector
  6. Otello STAMPACCHIA resignedDirector
  7. Robert Stuart COFFIN resignedDirector
  8. Colin LOVE appointedDirector
  9. Marco BOORSMA resignedDirector
  10. Richard LIM resignedDirector
  11. Jason Paul RHODES appointedDirector
  12. Marco BOORSMA appointedDirector
  13. Richard LIM appointedDirector
  14. Hugo Alexander SLOOTWEG appointedDirector
  15. Otello STAMPACCHIA appointedDirector
  16. JORDAN COMPANY SECRETARIES LIMITED resignedSecretary (corporate)
  17. JORDAN COMPANY SECRETARIES LIMITED appointedSecretary (corporate)
  18. Philip ASTLEY-SPARKE appointedDirector
  19. Robert Stuart COFFIN appointedDirector
  20. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current persons with significant control, and the end of each financial year with figures in the database. Former persons with significant control are not listed.